We are now in the later stages of the first generation of life extension, which involves applying the current class of pharmaceutical and nutritional knowledge to overcoming health challenges. In the 2020s we are starting the second phase of life extension, which is the merger of biotechnology with AI. The 2030s will usher in the third phase of life extension, which will be to use nanotechnology to overcome the limitations of our biological organs altogether.
Only one person, Jeanne Calment-a French woman who survived to age 122-is documented to have lived longer than 120 years. Actuarial data shows that from age 90 to 110, a person's chances of dying in the following year increase by about 2 percentage points annually. But from age 110 onward, the risk of death rises by about 3.5 percentage points a year.
[
add
]
[
|
|
...
]